BostonGene
BostonGene Closes $150M Series B Funding Round
The firm will use the financing to further the development, clinical expansion, and international availability of its Tumor Portrait tests.
The company hopes to validate its Tumor Portrait Test through several planned and ongoing clinical trials, while beginning to offer it overseas.
BostonGene Partners with NEC to Offer Tumor Portrait Tests Internationally
NEC, an investor in BostonGene, will initially help provide Tumor Portrait to hospitals in Japan using its healthcare and life science network.
MD Anderson, BostonGene Ink Collaboration to Develop Cancer Diagnostics
The partners will validate therapeutically actionable cancer biomarker targets and develop multiple tests from this research.